Last reviewed · How we verify
ABPO Forte Gel
ABPO Forte Gel is a topical formulation containing azelaic acid that reduces bacterial colonization and normalizes keratinization to treat acne and rosacea.
ABPO Forte Gel is a topical formulation containing azelaic acid that reduces bacterial colonization and normalizes keratinization to treat acne and rosacea. Used for Acne vulgaris, Rosacea.
At a glance
| Generic name | ABPO Forte Gel |
|---|---|
| Also known as | TactuPump Forte |
| Sponsor | Galderma R&D |
| Drug class | Topical antimicrobial and keratolytic agent |
| Target | Bacterial protein synthesis inhibition; mitochondrial oxidative stress in bacteria |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Azelaic acid works through multiple mechanisms: it inhibits the growth of Propionibacterium acnes and other acne-causing bacteria, reduces the production of inflammatory mediators, and normalizes follicular keratinization. The gel formulation provides enhanced penetration and tolerability for topical application to affected skin areas.
Approved indications
- Acne vulgaris
- Rosacea
Common side effects
- Skin irritation
- Erythema
- Pruritus
- Dryness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ABPO Forte Gel CI brief — competitive landscape report
- ABPO Forte Gel updates RSS · CI watch RSS
- Galderma R&D portfolio CI